Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-24

Clinical Trial Update: Lemborexant Augmentation of Naltrexone for Alcohol Craving and Sleep [Phase 3]

View source ↗

Summary

A Phase 3 study evaluated adding lemborexant to naltrexone to reduce alcohol craving and improve sleep in adults with alcohol use disorder; results have been po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lemborexant (lemborexant)
  • Naltrexone (Naltrexone)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Alcohol Use Disorder | Phase 3 | Status: COMPLETED | Results posted: 2026-03-24